Effectiveness of skin icing in reducing pain associated with goserelin acetate injection

Int J Clin Oncol. 2010 Oct;15(5):472-5. doi: 10.1007/s10147-010-0095-0. Epub 2010 Jun 11.

Abstract

Background: Goserelin acetate, which is injected through a 16-gauge needle, makes some patients feel substantial, although tolerable, pain. We tried to clarify whether injection pain was reduced by icing the skin at the injection site.

Methods: Pain associated with the injection of goserelin acetate was prospectively evaluated in 48 patients who had received an 10.8-mg goserelin injection at least once previously. In this study, the first injection was administered by usual methods, and 3 months later a second injection was administered after icing the skin at the injection site. Pain intensity was evaluated by visual analogue scale (VAS) pain score.

Results: VAS pain scores for the usual injection method were 32.4 ± 21.7 mm [mean ± 2 standard deviation (SD)] and was significantly lower (16.4 ± 17.9) for the icing method (p = 0.001, paired t test). Thirty-three (68.8%), eight (16.7%), and seven (14.6%) of the 48 patients reported a decrease, no change, and increase, respectively, in VAS pain score by the icing method.

Conclusions: Icing at the injection site of goserelin acetate is a safe and effective method to reduce injection pain. This method can be easily performed in daily practice if a patient complains of pain at the injection site.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Analgesia / methods*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Chi-Square Distribution
  • Cold Temperature*
  • Goserelin / administration & dosage*
  • Humans
  • Injections, Subcutaneous / adverse effects
  • Japan
  • Male
  • Middle Aged
  • Pain / etiology
  • Pain / prevention & control*
  • Pain Measurement
  • Prospective Studies
  • Prostatic Neoplasms / drug therapy*
  • Skin Temperature*

Substances

  • Antineoplastic Agents, Hormonal
  • Goserelin